CN103656078A - Traditional Chinese medicine for treating bone diseases - Google Patents

Traditional Chinese medicine for treating bone diseases Download PDF

Info

Publication number
CN103656078A
CN103656078A CN201210317661.8A CN201210317661A CN103656078A CN 103656078 A CN103656078 A CN 103656078A CN 201210317661 A CN201210317661 A CN 201210317661A CN 103656078 A CN103656078 A CN 103656078A
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
rhizoma
caulis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210317661.8A
Other languages
Chinese (zh)
Inventor
张娅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210317661.8A priority Critical patent/CN103656078A/en
Publication of CN103656078A publication Critical patent/CN103656078A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating bone diseases, belonging to the field of traditional Chinese medicine composition. The traditional Chinese medicine for treating bone diseases is prepared from the following raw medicines in parts by weight: 30-45 parts of caulis impatientis, 26-34 parts of dragon blood, 33-47 parts of semen strychni, 27-43 parts of ground beetle, 18-34 parts of scorpion, 26-40 parts of rhizoma dioscoreae, 43-56 parts of caulis sinomenii, 17-34 parts of panax pseudoginseng, 26-35 parts of rhizoma dioscoreae nipponicae, 32-45 parts of cortex eucommiae and 17-29 parts of notopterygium root. The traditional Chinese medicine for treating bone diseases disclosed by the invention has the advantages of good effect, low cost and little side effect.

Description

A kind of Chinese medicine for the treatment of osteopathia
Technical field
The invention belongs to the field of Chinese medicines.
 
Background technology
Orthopaedic disease is a kind of persistent ailment of serious harm human health, and it mainly comprises the said hyperosteogeny of modern medicine, rheumatism, arthritis, cervical spondylosis, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis, sciatica etc.As common prolapse of lumbar intervertebral disc and rheumatism.Prolapse of lumbar intervertebral disc is a kind of commonly encountered diseases, frequently-occurring disease, and has the trend of increasing year by year.Rheumatic osteopathia clinically sickness rate is high, and the cause of disease is complicated, and treatment difficulty is large, and relapse rate is high, is also a kind of comparatively common chronic disease and difficult disease.Two kinds of diseases all belong to the arthromyodynia category of the traditional Chinese medical science.Chinese medicine thinks, wind-cold damp pathogen invasion and attack, and acute and chronic trauma, causes meridians impatency, QI-blood circulation smooth and cause a disease, therefore forefathers have " numbness person closes also ", the saying of " bitterly obstructed, general rule is not bitterly ".Its morbidity of prolapse of lumbar intervertebral disc is the Anular disruption by lumbar intervertebral disc, and vertebral pulp is outstanding, compressing dural sac, nerve root and cause.Treatment to prolapse of lumbar intervertebral disc, the traditional Chinese medical science is with method treatments such as acupuncture, cupping, massages.Though said method can alleviate mechanical pressure effectively, it can not eliminate chemical stimulation effectively, and the course for the treatment of is longer, and doctor trained in Western medicine is with method treatments such as traction, computer reset, canalis sacralis therapy, operations.The medicine for the treatment of clinically rheumatic osteopathia is many and random, has many drawbacks, as glucocorticoid can cause hypertension blood fat, diabetes, osteoporosis and rebound phenomenon and withdrawal symptom.The side effect of NSAID (non-steroidal anti-inflammatory drug) ibuprofen is larger, often has side effect of digestive tract, headache, erythra etc.; Occasionally there are liver, renal function injury.
 
Summary of the invention
The object of the invention is to: for the defect of prior art, propose that a kind of cost is low, side effect is little, can be widely to the effective Chinese medicine of various osteopathia.
The object of the invention realizes by following technical proposals:
Treat a Chinese medicine for osteopathia, the raw material medicaments in part by weight of preparing this Chinese medicine comprises:
Caulis Impatientis 30-45 part,
Sanguis Draxonis 26-34 part,
Semen Strychni 33-47 part,
Eupolyphage sece steleophaga 27-43 part,
Scorpio 18-34 part,
Rhizoma Dioscoreae 26-40 part,
Caulis Sinomenii 43-56 part,
Radix Notoginseng 17-34 part,
Rhizoma Dioscoreae Nipponicae 26-35 part,
Cortex Eucommiae 32-45 part,
Rhizoma Et Radix Notopterygii 17-29 part.
 
As preferably, the raw material medicaments in part by weight of preparing this Chinese medicine also comprises:
Myrrha 20-40 part,
Stigma Croci 24-36 part,
Radix Aconiti Kusnezoffii 31-45 part,
Radix Saposhnikoviae 31-43 part.
 
As preferably, the raw material medicaments in part by weight of preparing this Chinese medicine comprises:
41 parts of Caulis Impatientiss,
29 parts of Sanguis Draxonis,
37 parts of Semen Strychni,
33 parts of eupolyphage sece steleophagas,
25 parts of Scorpios,
32 parts of Rhizoma Dioscoreaes,
44 parts of Caulis Sinomeniis,
28 parts of Radix Notoginseng,
32 parts of Rhizoma Dioscoreae Nipponicae,
44 parts of the Cortexs Eucommiae,
20 parts of Rhizoma Et Radix Notopterygiis.
 
As preferably, the raw material medicaments in part by weight of preparing this Chinese medicine forms:
44 parts of Caulis Impatientiss,
33 parts of Sanguis Draxonis,
41 parts of Semen Strychni,
30 parts of eupolyphage sece steleophagas,
22 parts of Scorpios,
36 parts of Rhizoma Dioscoreaes,
53 parts of Caulis Sinomeniis,
29 parts of Radix Notoginseng,
27 parts of Rhizoma Dioscoreae Nipponicae,
38 parts of the Cortexs Eucommiae,
18 parts of Rhizoma Et Radix Notopterygiis,
36 parts of Myrrhas,
34 parts of Stigma Crocis,
31 parts of Radix Aconiti Kusnezoffii,
43 parts of Radix Saposhnikoviaes.
 
Compatibility effect:
Caulis Impatientis: promoting blood circulation to remove blood stasis, reducing swelling and alleviating pain, the merit of performance internal diabetes, outer logical hundred keys, interior deep bone;
Sanguis Draxonis: blood circulation promoting competent silt, pain relieving, the merit of performance internal diabetes, outer logical hundred keys, interior deep bone;
Semen Strychni: liver and kidney tonifying, nourshing blood and promoting blood circulation, loose heat in blood, reunion of fractured tendons and bones, detumescence, pain relieving;
Eupolyphage sece steleophaga: removing blood stasis, reunion of fractured tendons and bones;
Scorpio: dispel the wind, relieving convulsion, dredging collateral, removing toxic substances;
Rhizoma Dioscoreae: spleen invigorating, reinforce the kidney, tonifying the lung, benefit essence;
Caulis Sinomenii: expelling wind and removing dampness, removing toxic substances pain relieving, detumescence dissipating blood stasis;
Radix Notoginseng: promoting blood circulation to remove blood stasis, reducing swelling and alleviating pain;
Rhizoma Dioscoreae Nipponicae: expelling wind and removing dampness, removing toxic substances pain relieving, detumescence dissipating blood stasis;
The Cortex Eucommiae: promoting blood circulation to remove blood stasis, reducing swelling and alleviating pain;
Rhizoma Et Radix Notopterygii: expelling wind and removing dampness, removing toxic substances pain relieving, detumescence dissipating blood stasis;
Myrrha: blood-activating and qi-promoting, reducing swelling and alleviating pain;
Stigma Croci: blood circulation promoting and blood stasis dispelling, dredging collateral;
Radix Aconiti Kusnezoffii: granulation promoting skin moistening, cure the wound comprehensively;
Radix Saposhnikoviae: granulation promoting skin moistening, cure the wound comprehensively.
 
Beneficial effect of the present invention: the present invention makes each efficacy of drugs produce synergism these drug regimens, thus replenishing QI to invigorate the spleen, tonifying the lung are reinforced the kidney effectively, expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral, reducing swelling and alleviating pain.Monarch, mutually coordination play altogether that replenishing QI to invigorate the spleen, tonifying the lung reinforce the kidney, the merit of expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral, reducing swelling and alleviating pain.Take a broad view of full side, heresy is gone and is not just hindered, and can be widely applicable for the treatment of various osteopathia.
 
The specific embodiment
Following non-limiting examples is used for illustrating the present invention.
embodiment 1:
Treat a Chinese medicine for osteopathia, the raw material medicaments in part by weight of preparing this Chinese medicine comprises:
41 parts of Caulis Impatientiss,
29 parts of Sanguis Draxonis,
37 parts of Semen Strychni,
33 parts of eupolyphage sece steleophagas,
25 parts of Scorpios,
32 parts of Rhizoma Dioscoreaes,
44 parts of Caulis Sinomeniis,
28 parts of Radix Notoginseng,
32 parts of Rhizoma Dioscoreae Nipponicae,
44 parts of the Cortexs Eucommiae,
20 parts of Rhizoma Et Radix Notopterygiis.
 
embodiment 2:
Treat a Chinese medicine for osteopathia, the raw material medicaments in part by weight of preparing this Chinese medicine forms:
44 parts of Caulis Impatientiss,
33 parts of Sanguis Draxonis,
41 parts of Semen Strychni,
30 parts of eupolyphage sece steleophagas,
22 parts of Scorpios,
36 parts of Rhizoma Dioscoreaes,
53 parts of Caulis Sinomeniis,
29 parts of Radix Notoginseng,
27 parts of Rhizoma Dioscoreae Nipponicae,
38 parts of the Cortexs Eucommiae,
18 parts of Rhizoma Et Radix Notopterygiis,
36 parts of Myrrhas,
34 parts of Stigma Crocis,
31 parts of Radix Aconiti Kusnezoffii,
43 parts of Radix Saposhnikoviaes.
 
embodiment 3:
Treat a Chinese medicine for osteopathia, the raw material medicaments in part by weight of preparing this Chinese medicine forms:
30 parts of Caulis Impatientiss,
26 parts of Sanguis Draxonis,
33 parts of Semen Strychni,
27 parts of eupolyphage sece steleophagas,
18 parts of Scorpios,
26 parts of Rhizoma Dioscoreaes,
43 parts of Caulis Sinomeniis,
17 parts of Radix Notoginseng,
26 parts of Rhizoma Dioscoreae Nipponicae,
32 parts of the Cortexs Eucommiae,
17 parts of Rhizoma Et Radix Notopterygiis.
20 parts of Myrrhas,
24 parts of Stigma Crocis,
31 parts of Radix Aconiti Kusnezoffii,
31 parts of Radix Saposhnikoviaes.
 
embodiment 4:
Treat a Chinese medicine for osteopathia, the raw material medicaments in part by weight of preparing this Chinese medicine forms:
45 parts of Caulis Impatientiss,
34 parts of Sanguis Draxonis,
47 parts of Semen Strychni,
43 parts of eupolyphage sece steleophagas,
34 parts of Scorpios,
40 parts of Rhizoma Dioscoreaes,
56 parts of Caulis Sinomeniis,
34 parts of Radix Notoginseng,
35 parts of Rhizoma Dioscoreae Nipponicae,
45 parts of the Cortexs Eucommiae,
29 parts of Rhizoma Et Radix Notopterygiis.
40 parts of Myrrhas,
36 parts of Stigma Crocis,
45 parts of Radix Aconiti Kusnezoffii,
43 parts of Radix Saposhnikoviaes.
 
embodiment 5:
Treat a Chinese medicine for osteopathia, the raw material medicaments in part by weight of preparing this Chinese medicine forms:
38 parts of Caulis Impatientiss,
31 parts of Sanguis Draxonis,
42 parts of Semen Strychni,
35 parts of eupolyphage sece steleophagas,
27 parts of Scorpios,
34 parts of Rhizoma Dioscoreaes,
54 parts of Caulis Sinomeniis,
27 parts of Radix Notoginseng,
29 parts of Rhizoma Dioscoreae Nipponicae,
39 parts of the Cortexs Eucommiae,
20 parts of Rhizoma Et Radix Notopterygiis,
36 parts of Myrrhas,
36 parts of Stigma Crocis,
40 parts of Radix Aconiti Kusnezoffii,
32 parts of Radix Saposhnikoviaes.
 
Usage and consumption
Decoct decoction, every day 2 times, a season is a course for the treatment of, and between two courses for the treatment of, interval is 2 weeks.
 
Clinical treatment group 100 examples of the present invention, prolapse of lumbar intervertebral disc 40 examples, hyperosteogeny 30 examples, fracture 15 examples, scapulohumeral periarthritis 15 examples; Treatment cycle is 1 course for the treatment of.In treatment group 100 examples, cure 76 examples, effective 87 examples.
 
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, all any modifications of doing within the spirit and principles in the present invention, be equal to and replace and improvement etc., within all should being included in protection scope of the present invention.

Claims (4)

1. treat a Chinese medicine for osteopathia, it is characterized in that the raw material medicaments in part by weight of preparing this Chinese medicine comprises:
Caulis Impatientis 30-45 part,
Sanguis Draxonis 26-34 part,
Semen Strychni 33-47 part,
Eupolyphage sece steleophaga 27-43 part,
Scorpio 18-34 part,
Rhizoma Dioscoreae 26-40 part,
Caulis Sinomenii 43-56 part,
Radix Notoginseng 17-34 part,
Rhizoma Dioscoreae Nipponicae 26-35 part,
Cortex Eucommiae 32-45 part,
Rhizoma Et Radix Notopterygii 17-29 part.
2. the Chinese medicine for the treatment of osteopathia as claimed in claim 1, is characterized in that the raw material medicaments in part by weight of preparing this Chinese medicine also comprises:
Myrrha 20-40 part,
Stigma Croci 24-36 part,
Radix Aconiti Kusnezoffii 31-45 part,
Radix Saposhnikoviae 31-43 part.
3. the Chinese medicine for the treatment of osteopathia as claimed in claim 1, is characterized in that the raw material medicaments in part by weight of preparing this Chinese medicine comprises:
41 parts of Caulis Impatientiss,
29 parts of Sanguis Draxonis,
37 parts of Semen Strychni,
33 parts of eupolyphage sece steleophagas,
25 parts of Scorpios,
32 parts of Rhizoma Dioscoreaes,
44 parts of Caulis Sinomeniis,
28 parts of Radix Notoginseng,
32 parts of Rhizoma Dioscoreae Nipponicae,
44 parts of the Cortexs Eucommiae,
20 parts of Rhizoma Et Radix Notopterygiis.
4. the Chinese medicine for the treatment of osteopathia as claimed in claim 2, is characterized in that: the raw material medicaments in part by weight of preparing this Chinese medicine forms:
44 parts of Caulis Impatientiss,
33 parts of Sanguis Draxonis,
41 parts of Semen Strychni,
30 parts of eupolyphage sece steleophagas,
22 parts of Scorpios,
36 parts of Rhizoma Dioscoreaes,
53 parts of Caulis Sinomeniis,
29 parts of Radix Notoginseng,
27 parts of Rhizoma Dioscoreae Nipponicae,
38 parts of the Cortexs Eucommiae,
18 parts of Rhizoma Et Radix Notopterygiis,
36 parts of Myrrhas,
34 parts of Stigma Crocis,
31 parts of Radix Aconiti Kusnezoffii,
43 parts of Radix Saposhnikoviaes.
CN201210317661.8A 2012-08-31 2012-08-31 Traditional Chinese medicine for treating bone diseases Pending CN103656078A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210317661.8A CN103656078A (en) 2012-08-31 2012-08-31 Traditional Chinese medicine for treating bone diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210317661.8A CN103656078A (en) 2012-08-31 2012-08-31 Traditional Chinese medicine for treating bone diseases

Publications (1)

Publication Number Publication Date
CN103656078A true CN103656078A (en) 2014-03-26

Family

ID=50295637

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210317661.8A Pending CN103656078A (en) 2012-08-31 2012-08-31 Traditional Chinese medicine for treating bone diseases

Country Status (1)

Country Link
CN (1) CN103656078A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104998131A (en) * 2015-09-03 2015-10-28 丁耀龙 Composition for promoting healing of injured bone and preparation method thereof
CN105496636A (en) * 2015-11-26 2016-04-20 武汉武达博硕园科技有限公司 External treatment device for rheumatism
CN108420902A (en) * 2017-02-15 2018-08-21 李克红 Ketorolac Linimentum of Chinese herbal medicine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104998131A (en) * 2015-09-03 2015-10-28 丁耀龙 Composition for promoting healing of injured bone and preparation method thereof
CN105496636A (en) * 2015-11-26 2016-04-20 武汉武达博硕园科技有限公司 External treatment device for rheumatism
CN108420902A (en) * 2017-02-15 2018-08-21 李克红 Ketorolac Linimentum of Chinese herbal medicine

Similar Documents

Publication Publication Date Title
CN103656078A (en) Traditional Chinese medicine for treating bone diseases
CN1861155A (en) Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby
CN1861171A (en) Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine
CN103284534A (en) Chinese medicine pillow core for treating cervical spondylosis and manufacturing method thereof
CN102526482A (en) Traditional Chinese medicine preparation for treating lumbar disc herniation
CN104258362A (en) Traditional Chinese medicine preparation for treating peripheral neuritis
CN1857636A (en) Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny
CN1284580C (en) Bone Activating stasis transforming capsule
CN101417059B (en) Ointment for treating burn and scald and preparation method thereof
CN101195002B (en) Chinese medicine emplastrum for releasing ache and health care
CN101450196A (en) Medicine for treating cervical vertebra disease
CN1843441A (en) Rheumatism-eliminating collaterals-dredging externally applied plaster
CN104173689A (en) Medicine for treating traumatic injury, lumbar disc herniation and scapulohumeral periarthritis and preparation method of medicine
CN104042736A (en) Traditional Chinese medicine oral liquid for treatment of ankylosing spondylitis
CN109010549A (en) Synthetism expelling wind and activating blood flow pain relieving ointment and preparation method thereof
CN102614350A (en) Chinese medicine for treating cervical spondylosis
CN104510793A (en) Traditional Chinese medicine formula for treating arthralgia
CN102343081A (en) Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching
CN101690750B (en) External medicine for curing hyperosteogeny
CN104147576B (en) A kind of external application medicated wine treating ischemic heart desease
CN101204525A (en) Tincture medicine for burn
CN101502598B (en) Medicament for treating protrusion of lumber vertebral disc and method for preparing the same
CN104383205A (en) Muscle relaxing and blood circulation stimulating medicine liquor externally used for treating orthopedic diseases
CN104587205B (en) A kind of medicine for treating fracture
CN104147230B (en) A kind of External apply medicinal wine for the treatment of ischemic heart desease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140326